| Bioactivity | RMC-113 is a PIP4K2C and PIKfyve inhibitor with the Ki vaules of 46 nM and 370 nM. RMC-113 reverses SARS-CoV-2-induced impairment of autophagic flux. RMC-113 shows antiviral activity[1]. |
| CAS | 2258606-34-5 |
| Formula | C21H15N3O2S |
| Molar Mass | 373.43 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Karim M, et al. PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2. Preprint. bioRxiv. 2024;2024.04.15.589676. Published 2024 Apr 17. |